These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 9331561

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.
    Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD.
    Cell; 1992 Sep 18; 70(6):923-35. PubMed ID: 1356076
    [Abstract] [Full Text] [Related]

  • 4. MYC abrogates p53-mediated cell cycle arrest in N-(phosphonacetyl)-L-aspartate-treated cells, permitting CAD gene amplification.
    Chernova OB, Chernov MV, Ishizaka Y, Agarwal ML, Stark GR.
    Mol Cell Biol; 1998 Jan 18; 18(1):536-45. PubMed ID: 9418900
    [Abstract] [Full Text] [Related]

  • 5. Loss of chromosomal integrity in neoplasia.
    Tlsty TD, Jonczyk P, White A, Sage M, Hall I, Schaefer D, Briot A, Livanos E, Roelofs H, Poulose B.
    Cold Spring Harb Symp Quant Biol; 1993 Jan 18; 58():645-54. PubMed ID: 7956081
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. High rate of CAD gene amplification in human cells deficient in MLH1 or MSH6.
    Chen S, Bigner SH, Modrich P.
    Proc Natl Acad Sci U S A; 2001 Nov 20; 98(24):13802-7. PubMed ID: 11717437
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Induction of CAD gene amplification by restriction endonucleases in V79,B7 Chinese hamster cells.
    Cavolina P, Agnese C, Maddalena A, Sciandrello G, Di Leonardo A.
    Mutat Res; 1989 Nov 20; 225(1-2):61-4. PubMed ID: 2563307
    [Abstract] [Full Text] [Related]

  • 11. Micronuclei formation with chromosome breaks and gene amplification caused by Vpr, an accessory gene of human immunodeficiency virus.
    Shimura M, Onozuka Y, Yamaguchi T, Hatake K, Takaku F, Ishizaka Y.
    Cancer Res; 1999 May 15; 59(10):2259-64. PubMed ID: 10344725
    [Abstract] [Full Text] [Related]

  • 12. Gene amplification in Chinese hamster DNA repair deficient mutants.
    Mondello C, Riboni R, Rady M, Giulotto E, Nuzzo F.
    Mutat Res; 1995 Feb 15; 346(2):61-7. PubMed ID: 7885401
    [Abstract] [Full Text] [Related]

  • 13. The propensity for gene amplification: a comparison of protocols, cell lines, and selection agents.
    Sharma RC, Schimke RT.
    Mutat Res; 1994 Jan 16; 304(2):243-60. PubMed ID: 7506368
    [Abstract] [Full Text] [Related]

  • 14. Late onset of CAD gene amplification in unamplified PALA resistant Chinese hamster mutants.
    Mucciolo E, Bertoni L, Mondello C, Giulotto E.
    Cancer Lett; 2000 Mar 31; 150(2):119-27. PubMed ID: 10704733
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of gene amplification in telomerase deficient immortalized mouse embryonic fibroblasts.
    Rebuzzini P, Martinelli P, Blasco M, Giulotto E, Mondello C.
    Carcinogenesis; 2007 Mar 31; 28(3):553-9. PubMed ID: 16973670
    [Abstract] [Full Text] [Related]

  • 16. Correlation of genetic instability and apoptosis in the presence of oncogenic Ki-Ras.
    Chen CY, Liou J, Forman LW, Faller DV.
    Cell Death Differ; 1998 Nov 31; 5(11):984-95. PubMed ID: 9846185
    [Abstract] [Full Text] [Related]

  • 17. 1-beta-D-arabinofuranosylcytosine enhancement of resistance to several antineoplastic drugs in mammalian tissue culture cells.
    Goz B, Carl PL, Tlsty TD.
    Mol Pharmacol; 1989 Sep 31; 36(3):360-5. PubMed ID: 2571071
    [Abstract] [Full Text] [Related]

  • 18. New mechanisms of gene amplification in drug resistance (the episome model).
    Von Hoff DD.
    Cancer Treat Res; 1991 Sep 31; 57():1-11. PubMed ID: 1686710
    [No Abstract] [Full Text] [Related]

  • 19. Fibroblast growth factor mediated alterations in drug resistance, and evidence of gene amplification.
    Huang A, Wright JA.
    Oncogene; 1994 Feb 31; 9(2):491-9. PubMed ID: 7904743
    [Abstract] [Full Text] [Related]

  • 20. Overexpression of the 18 kDa and 22/24 kDa FGF-2 isoforms results in differential drug resistance and amplification potential.
    Dini G, Funghini S, Witort E, Magnelli L, Fanti E, Rifkin DB, Del Rosso M.
    J Cell Physiol; 2002 Oct 31; 193(1):64-72. PubMed ID: 12209881
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.